Literature DB >> 29427417

TP53 Haploinsufficiency Rescues Emergency Granulopoiesis in FANCC-/- Mice.

Liping Hu1, Weiqi Huang1,2, Ling Bei1,2, Larisa Broglie3, Elizabeth A Eklund4,2.   

Abstract

Emergency (stress) granulopoiesis is an episodic process for the production of granulocytes in response to infectious challenge. We previously determined that Fanconi C, a component of the Fanconi DNA-repair pathway, is necessary for successful emergency granulopoiesis. Fanconi anemia results from mutation of any gene in this pathway and is characterized by bone marrow failure (BMF) in childhood and clonal progression in adolescence. Although murine Fanconi anemia models exhibit relatively normal steady-state hematopoiesis, FANCC-/- mice are unable to mount an emergency granulopoiesis response. Instead, these mice develop BMF and die during repeated unsuccessful emergency granulopoiesis attempts. In FANCC-/- mice, BMF is associated with extensive apoptosis of hematopoietic stem and progenitor cells through an undefined mechanism. In this study, we find that TP53 haploinsufficiency completely rescues emergency granulopoiesis in FANCC-/- mice and protects them from BMF during repeated emergency granulopoiesis episodes. Instead, such recurrent challenges accelerated clonal progression in FANCC-/-TP53+/- mice. In FANCC-/- mice, BMF during multiple emergency granulopoiesis attempts was associated with increased ataxia telangiectasia and Rad3-related protein (Atr) and p53 activation with each attempt. In contrast, we found progressive attenuation of expression and activity of Atr, and consequent p53 activation and apoptosis, in the bone marrow of FANCC-/-TP53+/- mice during this process. Therefore, activation of Atr-with consequent Fanconi-mediated DNA repair or p53-dependent apoptosis-is an essential component of emergency granulopoiesis and it protects the bone marrow from genotoxic stress during this process.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29427417      PMCID: PMC5834788          DOI: 10.4049/jimmunol.1700931

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

Review 1.  Homologous recombination in DNA repair and DNA damage tolerance.

Authors:  Xuan Li; Wolf-Dietrich Heyer
Journal:  Cell Res       Date:  2008-01       Impact factor: 25.617

2.  PU.1, interferon regulatory factor 1, and interferon consensus sequence-binding protein cooperate to increase gp91(phox) expression.

Authors:  E A Eklund; A Jalava; R Kakar
Journal:  J Biol Chem       Date:  1998-05-29       Impact factor: 5.157

3.  The role of Fas-associated phosphatase 1 in leukemia stem cell persistence during tyrosine kinase inhibitor treatment of chronic myeloid leukemia.

Authors:  W Huang; C-H Luan; E E Hjort; L Bei; R Mishra; K M Sakamoto; L C Platanias; E A Eklund
Journal:  Leukemia       Date:  2016-03-17       Impact factor: 11.528

4.  Myeloid development is selectively disrupted in PU.1 null mice.

Authors:  K L Anderson; K A Smith; K Conners; S R McKercher; R A Maki; B E Torbett
Journal:  Blood       Date:  1998-05-15       Impact factor: 22.113

5.  STAT3 governs distinct pathways in emergency granulopoiesis and mature neutrophils.

Authors:  Athanasia D Panopoulos; Ling Zhang; Jonathan W Snow; Daniel M Jones; Amber M Smith; Karim C El Kasmi; Fulu Liu; Mark A Goldsmith; Daniel C Link; Peter J Murray; Stephanie S Watowich
Journal:  Blood       Date:  2006-08-03       Impact factor: 22.113

6.  Fanconi anemia proteins stabilize replication forks.

Authors:  Lily Chien Wang; Stacie Stone; Maureen Elizabeth Hoatlin; Jean Gautier
Journal:  DNA Repair (Amst)       Date:  2008-09-25

7.  Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis.

Authors:  Brian Freie; Xiaxin Li; Samantha L M Ciccone; Kathy Nawa; Scott Cooper; Catherine Vogelweid; Laurel Schantz; Laura S Haneline; Attilio Orazi; Hal E Broxmeyer; Suk-Hee Lee; D Wade Clapp
Journal:  Blood       Date:  2003-07-10       Impact factor: 22.113

Review 8.  Leukemia and preleukemia in Fanconi anemia patients. A review of the literature and report of the International Fanconi Anemia Registry.

Authors:  A D Auerbach; R G Allen
Journal:  Cancer Genet Cytogenet       Date:  1991-01

9.  Inflammation triggers emergency granulopoiesis through a density-dependent feedback mechanism.

Authors:  Derek W Cain; Pilar B Snowden; Gregory D Sempowski; Garnett Kelsoe
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

10.  Stepwise activation of the ATR signaling pathway upon increasing replication stress impacts fragile site integrity.

Authors:  Stéphane Koundrioukoff; Sandra Carignon; Hervé Técher; Anne Letessier; Olivier Brison; Michelle Debatisse
Journal:  PLoS Genet       Date:  2013-07-18       Impact factor: 5.917

View more
  3 in total

1.  An induced pluripotent stem cell model of Fanconi anemia reveals mechanisms of p53-driven progenitor cell differentiation.

Authors:  William Marion; Steffen Boettcher; Sonya Ruiz-Torres; Edroaldo Lummertz da Rocha; Vanessa Lundin; Vivian Morris; Stephanie Chou; Anna M Zhao; Caroline Kubaczka; Olivia Aumais; Yosra Zhang; Akiko Shimamura; Thorsten M Schlaeger; Trista E North; Benjamin L Ebert; Susanne I Wells; George Q Daley; R Grant Rowe
Journal:  Blood Adv       Date:  2020-10-13

2.  Ruxolitinib ameliorates progressive anemia and improves survival during episodes of emergency granulopoiesis in Fanconi C-/- mice.

Authors:  Shirin Hasan; Liping Hu; Olatundun Williams; Elizabeth A Eklund
Journal:  Exp Hematol       Date:  2022-03-09       Impact factor: 3.084

Review 3.  Therapeutic Vulnerabilities of Transcription Factors in AML.

Authors:  Irum Khan; Elizabeth E Eklund; Andrei L Gartel
Journal:  Mol Cancer Ther       Date:  2020-11-06       Impact factor: 6.009

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.